The opportunity to be ‘tested for a genetic marker for skin cancer’ (Group 4) was appealing to participants who received MC1R testing, as many participants were unaware that variants could indicate an increased risk for developing skin cancer. The gene discussed is MC1R; the disease is skin neoplasm.